ValGenesis Appoints David Medina as Chief Marketing Officer to Spearhead Global Growth Strategy

ValGenesis Appoints David Medina as Chief Marketing Officer to Spearhead Global Growth Strategy

Althea D’Sylva, ValGenesis Communications, +1 510-445-0505 Ex. 1026, althea.dsylva@valgenesis.com

ValGenesis, the market leader in digital validation and risk management solutions for life sciences, is thrilled to announce the appointment of David Medina as Chief Marketing Officer (CMO), effective September 3, 2024. David joins ValGenesis with an impressive track record of driving marketing success across the enterprise SaaS, life sciences, and technology sectors.

David brings over two decades of experience in strategic marketing, having held senior leadership roles at industry giants such as Honeywell and Sparta Systems, with a deep focus on life sciences. Most recently, as Head of Customer Marketing at Honeywell Connected Enterprise, David led successful digital marketing transformations that generated significant growth in marketing-influenced pipeline for multiple business units.

Prior to his role at Honeywell, David served as CMO at Sparta Systems, where he revamped the company’s marketing strategy, resulting in a 33% CAGR in marketing-sourced revenue. His expertise in life sciences and ability to align marketing efforts with business goals make him the ideal leader to elevate ValGenesis' global brand presence and drive growth in new and existing markets. In his new role, David will oversee ValGenesis' global marketing strategy, brand positioning, and go-to-market initiatives.

“David’s visionary leadership and proven ability to deliver results in complex, competitive environments will be invaluable as we continue to expand our footprint in the life sciences sector. We are confident that his strategic approach to marketing will accelerate our growth and strengthen our position as a leader in digital validation solutions,” said Dr. Siva Samy, CEO & Chief Product Strategist of ValGenesis, Inc.

“I am excited to join ValGenesis at such a pivotal time,” said David Medina. “ValGenesis is at the forefront of innovation in digital validation and risk management, particularly in the life sciences sector. I look forward to working with the team to build on the company’s success and help drive its next growth phase.”

About ValGenesis

ValGenesis, Inc. is a pioneer in providing digital validation software that transforms the validation process for global life sciences companies. With its innovative solutions, ValGenesis enables companies to achieve compliance, reduce risks, and accelerate time-to-market for their products. The company’s platform is widely recognized as the most comprehensive digital validation solution in the market. For more information, visit www.valgenesis.com